The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
21-Apr-15
$NA
Target:
Tate & Lyle plc
Acquiror:
Archer Daniels Midland Company
Advised Tate & Lyle plc, a leading provider of ingredients and solutions to the food, beverage and other industries, on the re-alignment of Eaststarch C.V., its 50:50 corn wet milling joint venture in Europe with Archer Daniels Midland Company
21-Apr-15
$963 million
Target:
Refinancing of syndicated bank debt facilities
Acquiror:
Primary Health Care
Advised Primary Health Care on the refinancing of its A$1.25 billion syndicated bank debt facilities
27-Mar-15
$1.4 billion
Target:
AA plc
Advised AA plc, the UK’s leading roadside assistance provider, on the refinancing of its high yield bond and PIK instrument
06-Mar-15
$NA
Target:
Kerry Pinnacle
Acquiror:
Pacific Equity Partners
Advised Kerry Group plc, a global leader in food ingredients and flavor technologies, on the sale of its Australian subsidiary Kerry Pinnacle, an integrated manufacturer and distributor of bakery ingredients and prepared bakery products, to Pacific Equity Partners
03-Mar-15
$66 million
Target:
The Warehouse Group Limited
Advised Woolworths Limited, Australia’s largest supermarket operator, on strategic options for the divestment of its 8.8% holding in The Warehouse Group, New Zealand’s largest general merchandise retailer
02-Mar-15
$107 million
Target:
Lion's Everyday Cheese Business
Acquiror:
Warrnambool Cheese & Butter
Advised Lion, a leading Australasian food and beverage company wholly owned by Japanese conglomerate Kirin, on the sale of its Everyday Cheese business to Warrnambool Cheese & Butter, a listed Australian dairy company controlled by the Canadian dairy player Saputo
01-Oct-14
$NA
Target:
Modern Star Pty Ltd
Acquiror:
Navis Capital
Advised Modern Star, Australia and New Zealand’s #1 supplier of education resources and educational toys, on the sale of 90% of its shares to Navis Capital, a leading private equity group focused on investments in South and Southeast Asia
11-Aug-14
$NA
Target:
MannKind Corporation
Acquiror:
Sanofi
Advised MannKind, a biopharmaceutical company focused on the development of therapeutic products for patients with diabetes, on a collaboration with Sanofi, comprising licensing, supply and loan facility agreements with respect to licensing the Company’s lead product AFREZZA. MannKind will receive up to $925 million in upfront and milestone payments plus 35% of future profits.
05-Aug-14
$1.3 billion
Target:
Siemens Health Services
Acquiror:
Cerner Corporation
Advised Cerner Corporation, a leader in healthcare information services, on the acquisition of the assets of Siemens Aktiengesellschaft’s healthcare information technology business unit, Siemens Health Services, for $1.3 billion in cash.
28-Jul-14
$90 million
Target:
Clinuvel Pharmaceuticals Limited
Acquiror:
Retrophin, Inc.
Advised Clinuvel, a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders, in response to an unsolicited proposal to acquire the business from Retrophin, a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases
25-Jul-14
$NA
Target:
Stakes in David Jones and Country Road
Acquiror:
Woolworths Holdings
Advised Solomon Lew in reviewing his strategic options in relation to David Jones and Country Road. Mr Lew ultimately sold his 11.8% stake in the tightly held Country Road to Woolworths Holdings. Woolworths Holdings also acquired David Jones, Australia’s premier department store, in which Mr Lew held a 9.9% stake
06-Jun-14
$7.2 billion
Target:
AA Limited
Advised the management buy-in team on the acquisition by leading institutional investors of AA Limited from Acromas and simultaneous listing on the London Stock Exchange
10-Mar-14
$NA
Target:
K-Y brand
Acquiror:
Reckitt Benckiser Group plc
Advised Reckitt Benckiser, a leading consumer goods manufacturer, on the acquisition of the global rights to the K-Y brand, a leader in intimate lubricants
18-Feb-14
$25.1 billion
Target:
Forest Laboratories Inc.
Acquiror:
Actavis plc
Advised Actavis plc, a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products on its acquisition of Forest Laboratories Inc.
09-Dec-13
$NA
Target:
Lazada Group GmbH
Acquiror:
Tesco plc
Advised Tesco plc, a listed FTSE 100 retailer, on its acquisition of a significant minority shareholding in Lazada, the leading online general merchandise retailer in South East Asia
04-Dec-13
$850 million
Target:
Megapolis Distribution
Acquiror:
Japan Tobacco Inc
Advised Japan Tobacco Inc in connection with the acquisition of a minority stake in Megapolis Distribution B.V., Russia’s leading tobacco distributor
02-Oct-13
$NA
Target:
Tesco PLC's Chinese retail operations
Acquiror:
China Resources Enterprise
Advised Tesco PLC on the formation of a joint venture with China Resources Enterprise, a Hong Kong listed, Chinese retailer, to create the leading multi-format retailer in China
10-Sep-13
$NA
Target:
Fresh & Easy (owned by Tesco plc)
Acquiror:
YFE Holdings, Inc (affiliate of The Yucaipa Companies, LLC)
Advised Tesco plc, a listed FTSE 100 retailer, on the sale of a substantive part of Fresh & Easy’s operating business to YFE Holdings, Inc, an affiliate of The Yucaipa Companies, LLC
09-Sep-13
$2.1 billion
Target:
Lucozade & Ribena brands (owned by GSK)
Acquiror:
Suntory Beverage & Food Ltd
Advised GlaxoSmithKline, the UK listed international pharmaceutical and consumer company, on the sale of its nutritional drinks brands Lucozade and Ribena to Suntory Beverage & Food Ltd
20-May-13
$8.5 billion
Target:
Warner Chilcott, plc
Acquiror:
Actavis, Inc.
Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc
26-Apr-13
$NA
Target:
Yakult Honsha
Acquiror:
Danone
Advised Danone, a world leading food company, on its business and capital alliance with Yakult Honsha, the largest probiotic dairy product manufacturer in Japan
20-Feb-13
$120 million
Target:
Trivett Automotive Group
Acquiror:
Inchcape plc
Advised Inchcape plc, the leading independent international automotive distributor and retailer, on the acquisition of Trivett Automotive Group, the leading luxury and premium automotive group in Australia
07-Dec-12
$43 million
Target:
Champion Flour Limited
Acquiror:
Nisshin Seifun Group Inc.
Advised Goodman Fielder, a leading Australian listed food company, on the sale of its New Zealand flour milling business, Champion Flour, to Nisshin Seifun Group Inc.
26-Sep-12
$NA
Target:
Dick Smith Electronics, a subsidiary of Woolworths Limited
Acquiror:
Anchorage Capital Partners
Advised Woolworths Limited, Australia’s largest supermarket operator, on the sale of its Consumer Electronics retail chain, Dick Smith Electronics, to Anchorage Capital Partners
01-Aug-12
$4.0 billion
Target:
Mediclinic International Limited
Advised Mediclinic International, South Africa’s second largest and Switzerland’s largest provider of private hospital services, on the restructuring of its entire balance sheet, including $2.2 billion debt refinancing in Switzerland and a $0.6 billion rights issue in South Africa